News Agency
Men's Weekly

Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets

  • Written by Media Outreach
SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc. to launch and commercialise Libtayo® (cemiplimab), a fully human monoclonal antibody...

Read more: Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South...

Delivering Consistent Brand Messaging Across Global Markets: Building Unity Without Losing Local Relevance

Global expansion is both opportunistic and complicated. As companies venture into new, international territories, they must consider language differences, cultural dynamics, regulatory systems, and consumer needs. However, localization does not mean that a consistent brand message should be sacrificed. A... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion